Q3 2024 Earnings Estimate for Aclaris Therapeutics, Inc. Issued By HC Wainwright (NASDAQ:ACRS)
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Free Report) – Investment analysts at HC Wainwright boosted their Q3 2024 EPS estimates for shares of Aclaris Therapeutics in a research note issued on Monday, July 22nd. HC Wainwright analyst R. Selvaraju now forecasts that the biotechnology company will earn ($0.14) per share for the quarter, up from their […]
More Stories
Wall Street Review: Small Caps Outperform as Bond Yields Ease
By Panos Mourdoukoutas Small-cap stocks outperformed this week as investors rotated out of the volatile AI trade and into interest-rate-sensitive...
Judge Rejects Bail for Former OpenAI Employee Accused of Installing Listening Device
By Lear Zhou SAN FRANCISCO—A federal judge rejected a bail request of a former OpenAI engineer who was accused of...
Trump Announces $4.2 Billion Audi Auto Manufacturing Investment in Georgia
By Travis Gillmore PERRY, Ga.– President Donald Trump unveiled a $4.2 billion investment from automaker Audi to develop its first...
DOJ Gives California County Election Officials 48 Hours to Help Verify Voters’ Citizenship
By Tom Gantert The U.S. Department of Justice has sent letters to county election officials in California warning them they...
French Officials Say 1,300 Arrests Made Amid Latest Unrest
By Jack Phillips More than 1,300 people were arrested in another day of protests and riots, after a mass march...
RFK Jr. Announces American-Made Seafood Label at Midterm Rally in Florida
By Troy Myers Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has announced a new American-made label for...